Is It Time to Buy Salesforce Stock With AI Agent Momentum Mounting?

Salesforce reported fiscal Q3 FY26 revenue of $10.26 billion, up 9% year-over-year and roughly in line with guidance, with subscription and support revenue of $9.73 billion (+10%). AI agent platform Agentforce ARR surged 330% to $540 million (9,500 paid deals; 18,500 total deals) and combined Agentforce+Data360 ARR rose 114% to $1.4 billion, while platform sales growth accelerated to 19%; adjusted EPS beat at $3.25 (+35% vs. consensus $2.86). The company generated $2.3 billion of operating cash flow and $2.2 billion of free cash flow, repurchased $3.8 billion of stock, ended the quarter with $11.3 billion in cash and $8.4 billion of debt, and raised FY26 guidance to $41.45–41.55 billion (9–10% growth) and adjusted EPS to $11.75–11.77; valuation measures show forward P/S ~5.3 and forward P/E ~19.5. Despite strong AI traction and improved guidance, management says Agentforce has not yet meaningfully accelerated overall revenue beyond high-single to low-double-digit growth, leaving upside contingent on broader AI monetization.

Analysis

Market structure: Salesforce (CRM) is the direct beneficiary — Agentforce ARR up 330% to $540M and combined Agentforce+Data360 ARR $1.4B signal product-led share gains in enterprise AI tooling, while AI-infra names (NVDA) and data-engine partners (Snowflake, MDB) also benefit from incremental GPU/cloud spend. Competitors that rely on per-seat pricing (HUBS, DDOG) face pricing pressure as customers shift to usage- or outcome-based AI billing; platform revenue (19% growth) outpacing core apps implies rising wallet-share for platform incumbents. Liquidity/cashflow (FCF $2.2B, $11.3B cash) and $3.8B buybacks compress free float, supporting equity but leaving limited credit stress (debt $8.4B) — minimal immediate bond-market impact, modest upward pressure on IG spreads if macro weakens.

Risk assessment: Key tail risks are regulatory limits on data use or AI model liability, a macro-driven reduction in enterprise IT spend, and slower-than-expected monetization if per- seat pricing cannibalizes ARPU; probability medium but impact high. Near-term (days-weeks) volatility around guidance/earnings; short-term (3–6 months) risk that Agentforce conversion stalls; long-term (12–36 months) upside if Agentforce shifts company growth >15% CAGR. Hidden dependencies include third-party LLM costs (NVDA/GPU supply) and Data 360 quality — if model costs rise 20–30%, margins and pricing could be squeezed. Catalysts: upcoming fiscal Q4 results, large multi-year Agentforce renewals, and regulatory announcements.

Key Decisions for Investors

• Establish a 2–3% long position in Salesforce (CRM) immediately; plan to add to a 4–6% position if CRM drops another 10% or if next quarter Agentforce+Data360 ARR grows sequentially by >35%. Target 12–24 month hold; trim into strength if forward P/S expands above 7x or realized ARR growth fails to exceed 20% YoY.
• Implement a CRM options overlay: sell 6–10 week 5–7% OTM covered calls on 25–50% of the core position to harvest volatility premium, and simultaneously sell cash-secured puts 8–12% OTM to acquire additional exposure at a lower basis (only if willing to hold 12+ months).
• Execute a relative-value pair: go long CRM (3% weight) and short Datadog (DDOG) or another high-multiple observability/ SaaS name (2% weight) for 3–9 months to capture valuation compression; exit if CRM/DDOG spread tightens to historical mean or if DDOG outperforms by >15% on fundamentals.
• Allocate 1–2% to NVDA (or a 6–9 month call spread) as an explicit hedge/capture of AI-infra tailwinds that underpin Agentforce economics; increase only if NVDA supply dynamics (GPU availability) or enterprise AI spend indicators improve over the next 90 days.